Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Unit price / market price
-
$1.61
-
Total 13F principal
-
$87,500,000
-
Principal change
-
+$2,150,000
-
Total reported value
-
$141,157,000
-
Number of holders
-
12
-
Value change
-
+$3,228,692
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q1 2016
As of 31 Mar 2016 LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 had 12 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $87,500,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included LINDEN ADVISORS LP, UBS ASSET MANAGEMENT AMERICAS INC, CITADEL ADVISORS LLC, UBS OCONNOR LLC, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, ANGELO GORDON & CO., L.P., Polygon Management Ltd., Clearbridge Investments, LLC, and Verition Fund Management LLC.
This table shows 12 bond principal holders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.